Tag: drug

Drugs, Crime, Mental Illness, and the Homeless: Can We Solve the Crisis in Our Cities?

Americans living in cities such as New York, Los Angeles, and San Francisco see first-hand on their streets the results of ideology and failed policies: the homeless encampments, skyrocketing crime, and open-air drug markets. In a recent episode of “American Thought Leaders,” host Jan Jekielek discusses the causes and possible solutions to this ongoing ruination…


How Migrant Surge at the Border Fuels Massive American ODs From Tiny Grains of This Killer Drug

On a September afternoon, Allyssia Solorio wondered why her energetic young brother hadn’t emerged from his bedroom in their Sacramento, Calif., home. When she opened his door, she saw 23-year-old Mikael leaning back on his bed with his legs dangling over the side. She rushed to her brother and shook him, but to no avail….


Drug, Feed Ingredient Shortages Hit US Livestock Producers

CHICAGO—Michigan dairy farmer Doug Chapin has been unable to buy bottles of veterinary penicillin for his cows for more than a month. In Minnesota, pig farmer Randy Spronk reformulated feed rations due to a shortage of the widely used ingredient lysine, an amino acid that helps livestock grow. Supply-chain disruptions are hitting America’s meat producers…


5 Fentanyl Poisonings at Westminster Park

WESTMINSTER, Calif.—Five individuals were hospitalized after overdosing on what is believed to be fentanyl after they were found unresponsive inside Westminster’s Sigler Park. Police arrived at 5:55 p.m. Nov. 13 at the park after someone called in regarding multiple unconscious people near the bathrooms, according to Sgt. Alan Aoki of the Westminster Police Department. After arrival, officers…


Merck Raises Full-Year Profit Target After Cancer Drug Sales Help Third-Quarter Beat

Merck & Co. Inc. raised its full-year adjusted profit forecast on Thursday, after strong demand for its blockbuster cancer drug Keytruda and recovery in sales of its non-COVID-19 vaccines helped it beat third-quarter profit estimates. Sales of vaccines and physician-administered drugs have started to improve as hospitals and clinics adapt to the pandemic, helping Merck,…


NTD Business Full Broadcast (Oct. 1)

Inflation, a key indicator closely watched by the Fed, is still at historically high levels. Is it going to slow down growth going forward? Drugmaker Merck’s stock is up 8 percent Friday. It says its experimental drug for COVID-19 cuts the risk of death or hospitalization by 50 percent. It’s applying for emergency use with…


Merck to Buy Acceleron for About $11.5 Billion in Rare Disease Drug Push

Merck & Co. is buying Acceleron Pharma Inc. for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in fresh revenue. The deal gives Merck access to Acceleron’s rare disease drug candidate, sotatercept, which the company expects to be a multi-billion dollar peak sales opportunity, and comes…


Mirum’s Oral Drug Becomes First U.S. Approved Alagille Syndrome Therapy

Mirum Pharmaceuticals Inc said its drug became the first U.S.-approved therapy for treating itching in patients with rare liver disorder Alagille syndrome (ALGS), and would be available for distribution immediately. Shares of the company were briefly halted before the approval and rose as much as 8.8% to $20.40 after resumption on Wednesday. “(Itching) is really…


Drug Distributors Strike First Opioid Settlement With Native American Tribe for $75 Million

The three largest U.S. drug distributors will pay more than $75 million to resolve claims they fueled an opioid epidemic in the Cherokee Nation’s territory in Oklahoma, marking the first settlement with a tribal government in the litigation over the U.S. addiction crisis. Cherokee Nation Principal Chief Chuck Hoskin on Tuesday said the settlement, which…


Moderate Democrats Introduce Rival Drug Pricing Plan, Imperiling Pelosi-Backed Proposal

A group of five moderate Democrats on Tuesday unveiled a new bill to slash drug costs, signaling their party may be unable to muster enough votes to pass a larger drug pricing proposal. The larger plan is backed by House Speaker Nancy Pelosi (D-Calif.) and President Joe Biden. It is part of of congressional Democrats…